Profit warning pummels Lunar's stock
Shares of bone densitometry vendor Lunar plunged on Sept. 22 after the Madison, WI, company announced that it expected to post flat revenues and lower profits for its first fiscal quarter (end-September). The results were due to lower-than-expected
Shares of bone densitometry vendor Lunar plunged on Sept. 22 after the Madison, WI, company announced that it expected to post flat revenues and lower profits for its first fiscal quarter (end-September). The results were due to lower-than-expected densitometry sales in Japan and in the U.S., where many physicians have been confused about proposed reductions in the Medicare reimbursement rate for bone densitometry, according to the company. Lunar's stock dropped $4.56 a share, or 19%, to close at $19.44 on Sept. 22, the first day of trading after the news was announced.
In other Lunar news, the company in early September began shipping Pixi, its compact dual-energy x-ray absorptiometry (DEXA) densitometer. Pixi is targeted at the physician-office market and carries a list price of $32,000. Lunar shipped the first Pixi unit to a physician in the Washington, DC, area, according to the company.
New Collaboration Offers Promise of Automating Prior Authorizations in Radiology with AI
March 26th 2025In addition to a variety of tools to promote radiology workflow efficiencies, the integration of the Gravity AI tools into the PowerServer RIS platform may reduce time-consuming prior authorizations to minutes for completion.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
